baber/WOPTO huggingface dataset:
Patent EP-3973640-A1 (EP)
Inventor: ONGGOSANUSI EKO
IPC: H04B7/06
Filed: 2020-07-15
Abstract: La présente invention concerne des procédés et des appareils de rapport de faisceau. Un procédé de fonctionnement d'un équipement utilisateur (UE) consiste à recevoir, à partir d'une station de base, des informations de configuration sur un rapport de faisceau et un ensemble de ressources de rapport de liaison montante (UL) ; à recevoir au moins une ressource de signal de référence (RS) ; à mesurer l'au moins une ressource de RS pour calculer le rapport de faisceau ; et à transmettre le rapport de faisceau sur au moins une ressource de rapport UL provenant de l'ensemble de ressources de rapport UL après la survenue d'un événement.
Patent EP-4082089-A1 (EP)
Inventor: HAUGAN ESPEN
IPC: H02J5/00
Filed: 2020-12-21
Abstract: An electrical energy distribution system (1) for a vessel or platform comprises a plurality of DC buses (DC BB1, DC BB2, DC BB3, DC BB4), each DC bus coupled to a corresponding energy storage bus (ES BB1, ES BB2, ES BB3, ES BB4); each energy storage bus being coupled to a neighbouring energy storage bus of the system through a first DC/DC converter (10, 11, 12, 13). The plurality of energy storage buses are connected together to form a ring. Each energy storage bus is further coupled to an energy store (14, 15, 16, 17) through a second DC/DC converter (18, 19, 20, 21).
Patent EP-4081498-A1 (EP)
Inventor: THALER ARNE
IPC: C07C17/367
Filed: 2020-12-17
Abstract: The process produces a fluorinated olefin from a fluorinated copolymer having at least one of sulfonic acid groups, carboxylic acid groups, or salts thereof. The process includes heating the fluorinated copolymer at a first temperature not more than 450 ̊ C to decompose at least one of the sulfonic acid groups, carboxylic acid groups, or salts thereof to form a partially pyrolyzed intermediate and subsequently heating the partially pyrolyzed intermediate at a second temperature of at least 550 ˚C to produce the fluorinated olefin.
Patent EP-4076534-A1 (EP)
Inventor: RÖSCH FRANK
IPC: A61K103/00
Filed: 2020-12-17
Abstract: The invention relates to a smart drug delivery system for dual nuclear medical cytotoxic theranostics, comprising – a first compound with the structure: or – a second compound with the structure Chel—S—TV and a third compound with the structure CT—L—TV; in the first, second and third compounds Chel being a radical of a chelating agent for complexing a radioisotope; CT is a radical of a cytotoxic compound; TV is a biological targeting vector; L1 and L are each linkers; S1, S2 and S are each spacers.
Patent EP-3993509-A1 (EP)
Inventor: HUANG YUAN
IPC: H04W76/30
Filed: 2020-07-24
Abstract: Methods for network connection control are provided. A first Access Point (AP) is accessed through a first Wireless-Fidelity (Wi-Fi) network interface of the electronic device, and accessing a second AP through a second Wi-Fi network interface of the electronic device. Connection with the second AP is disconnected in response to detecting a first Internet Protocol (IP) address of the first AP and a second IP address of the second AP are same. A third AP is determined based on a first Media Access Control (MAC) address of the first AP and a second MAC address of the second AP. A third AP is accessed through the second Wi-Fi network interface. Determining the third AP according to the first MAC address of the first AP and the second MAC address of the second AP, and then accessing the third AP, is beneficial to release the corresponding connection and re-selecting a new hotspot in time when there is a gateway IP conflict and the electronic device is in dual Wi-Fi mode. It guarantees the network quality and is conducive to improve the efficiency and convenience of network connection control.
Patent EP-4034774-A1 (EP)
Inventor: BUTTERFIELD MARK
IPC: F16B35/06
Filed: 2020-09-24
Abstract: Des aspects de la présente invention concernent de manière générale un élément de fixation ayant une forme de section transversale disco-rectangulaire. Cette forme est avantageuse à des fins de préhension et du fait que la forme disco-rectangulaire fournit un espace entre les bords d'un alésage fraisé et les bords de la forme disco-rectangulaire. Ainsi, un utilisateur de la forme disco-rectangulaire peut être apte à saisir les bords de la forme disco-rectangulaire, avec les doigts ou tout autre type d'outil.
Patent EP-4040841-A1 (EP)
Title: Communication control method and relay device
Inventor: FUJISHIRO MASATO
IPC: H04W84/18
Filed: 2020-09-23
Abstract: A communication control method is executed in a relay apparatus including a base station function processor connecting wirelessly to a lower apparatus, and a user equipment function processor connecting wirelessly to an upper apparatus, the relay apparatus relaying upstream data from the lower apparatus to the upper apparatus. The communication control method includes configuring a number of target hops indicating the number of hops from the relay apparatus to a lowest apparatus among one or more of the lower apparatuses to be covered in a buffer state report, and transmitting, to the upper apparatus, the buffer state report indicating an amount of untransmitted upstream data of each of at least one apparatus, among the relay apparatus and the one or more of the lower apparatuses, corresponding to the configured number of target hops.
Patent EP-4046637-A1 (EP)
Title: External preparation for treating epilepsy or autism spectrum disorder
Inventor: KANEDA MARI
IPC: A61K9/06
Filed: 2020-10-07
Abstract: It is an object to provide a highly safe and easy-to-administer pharmaceutical preparation for treating epilepsy, pharmaceutical preparation for treating an autism spectrum disorder, and/or pharmaceutical preparation for treating an anxiety disorder. [Solving Means] A topical preparation containing as an active ingredient at least one selected from the group consisting of sirolimus and a sirolimus derivative is a pharmaceutical preparation that is easy to administer, and is highly safe as a therapeutic agent for epilepsy, an autism spectrum disorder, and/or an anxiety disorder. Suitable examples of the active ingredient include sirolimus, everolimus, temsirolimus, ridaforolimus, and zotarolimus.
Patent EP-4048852-A1 (EP)
Inventor: MOROZOV KONSTANTIN E
IPC: E21B10/567
Filed: 2020-09-24
Abstract: A cutter element for a drill bit includes a base portion having a central axis, a first end, and a second end. In addition, the cutter element includes a cutting layer fixably mounted to the first end of the base portion. The cutting layer includes a cutting face distal the base portion. The cutting face includes a first planar surface and a second planar surface that is circumferentially-spaced from the first planar surface. Each planar surface is positioned at an outer periphery of the cutting face adjacent the radially outer surface of the cutting layer. The cutting face also includes a saddle surface including a crown and a pair of lateral side surfaces that slope down and away from the crown toward the radially outer cylindrical surface of the cutting layer. The crown extends from the first planar surface to the second planar surface.
Patent EP-4056291-A1 (EP)
Title: Method for separating lithium
Inventor: NISHIKAWA CHIHIRO
IPC: C22B3/04
Filed: 2020-09-10
Abstract: Provided is a method for separating lithium from a lithium solution containing lithium by 200 mg/L or more and fluorine by 20 mg/L or more, the method including: a first removal step of adding a first component, which solidifies the fluorine contained in the lithium solution, to the lithium solution and removing the fluorine solidified to obtain a F-removed liquid; and a second removal step of adding a second component, which solidifies the first component remaining in the F-removed liquid, to the F-removed liquid and removing the first component solidified to obtain a first component-removed liquid.
Patent EP-4115898-A1 (EP)
Inventor: QI HYATT
IPC: A61P25/28
Filed: 2020-11-09
Abstract: A pharmaceutical composition for treating senile dementia. The composition contains a therapeutically effective amount of nerve growth factors or nerve growth factor precursors of Agkistrodon or viper of the viperidae family, and a pharmaceutically acceptable carrier base for use in reversing or relieving the symptoms of senile dementia.
Patent EP-4062411-A1 (EP)
Inventor: SAMS AARON J
IPC: G16B40/00
Filed: 2020-11-17
Abstract: The present disclosure provides methods of estimating a degree of ancestral relatedness between individuals. In an aspect, a method comprises receiving haplotype data comprising genetic markers shared among a population of individuals; dividing the haplotype data into segments based on the genetic markers; for each of the population of test individuals: (i) based on the genetic markers, matching segments of the haplotype data that are identical-by-descent between two individuals, (ii) for each of the matched segments: dividing the matched segment into discrete genomic intervals, scoring each of the discrete genomic intervals based on a degree of matching within or between the individuals, correcting the scores for consistency, and (iii) calculating a weighted sum over the discrete genomic intervals of the matched segment, based on the corrected scores and assigned weights; and (d) estimating the degree of ancestral relatedness between the individuals based on the weighted sums of the matched segments.
Patent EP-4066436-A1 (EP)
Inventor: YU WANTAO
IPC: H04L9/08
Filed: 2020-03-31
Abstract: Methods, apparatus, and systems to establish a secure communication in a wireless network are described. In one example aspect, a wireless communication method includes generating, by a first function entity, a first identifier configured to be used to establish a secure communication for a first device, using at least a mobile country code, a mobile network code, and a random number, and transmitting the first identifier to the first device.
Patent EP-4061833-A1 (EP)
Inventor: NESTI EDMUND
IPC: C07K14/47
Filed: 2020-11-20
Abstract: The invention relates to compounds, compositions, and methods for derepressing RE1 silencing transcription factor (REST) target genes are provided. In particular, a peptide having the sequence TEDLEPPEPPLPKEN (SEQ. ID NO: 1) and EDLEPPEPPLPK (SEQ. ID NO: 15), or the reversed sequences made of D-amino acids (retro inverted, RI) nekplppeppeldet (SEQ ID NO: 16) and kplppeppelde (SEQ ID NO: 17), are disclosed for inhibiting REST activity. The peptides are useful to treat, prevent, or ameliorate conditions such as traumatic brain injury, epilepsy, dementia, Huntington's Disease (HD), chronic pain, brain cancer (including glioblastoma multiforme), pancreatic cancer; diabetes, and peripheral nerve injury
Patent EP-4060949-A1 (EP)
Inventor: ZHANG ZHENDONG
IPC: H04L12/705
Filed: 2020-09-29
Abstract: This application discloses a routing loop reduction method, an apparatus, and a system. The method includes: A first network device receives a first packet. The first packet carries identifier information and a first route, and the identifier information includes a source device identifier of a device that advertises the first route or a source protocol identifier of a routing protocol to which the first route belongs. The first network device runs a first routing protocol and a second routing protocol, and the first routing protocol is different from the second routing protocol. The first network device determines, based on the identifier information, that advertising the first route to a second network device running the second routing protocol causes a routing loop. Therefore, the first network device does not advertise the first route to the second network device. Alternatively, the first network device reports alarm information. The alarm information indicates that the routing loop occurs when the first network device advertises the first route to the second network device. The method and the apparatus are used to resolve a technical problem that loop failure locating and recovery are difficult and time-consuming.
Patent EP-4076469-A1 (EP)
Title: Ophthalmic compositions comprising d2o
Inventor: OSTROW GREGORY I
IPC: A61K31/5575
Filed: 2020-12-15
Abstract: Provided herein is an ophthalmic composition. In some embodiments, the ophthalmic composition includes a low concentration of an ophthalmic agent for treatment of an ophthalmic disorder or condition. Further disclosed herein is an ophthalmic composition including a low concentration of an ophthalmic agent and deuterated water. Further disclosed herein is an ophthalmic including a low concentration of an ophthalmic agent and various ratios of water to deuterated water.
Patent EP-4079708-A1 (EP)
Title: Cubic boron nitride sintered body and method for manufacturing same
Inventor: ABE MACHIKO
IPC: C04B35/645
Filed: 2020-10-29
Abstract: A cubic boron nitride sintered material includes: more than or equal to 40 volume% and less than or equal to 85 volume% of cubic boron nitride grains; and a binder phase, wherein the binder phase includes at least one selected from a group consisting of one or more first compounds and a solid solution originated from the first compounds, or includes at least one selected from a group consisting of the one or more first compounds and the solid solution originated from the first compounds and an aluminum compound, the one or more first compounds consisting of at least one element selected from a group consisting of titanium, zirconium, hafnium, vanadium, niobium, tantalum, chromium, molybdenum, and tungsten, and at least one element selected from a group consisting of nitrogen, carbon, boron, and oxygen, the cubic boron nitride grains include, on number basis, more than or equal to 50% of cubic boron nitride grains each having an equivalent circle diameter of more than 0.5 µm, and includes, on number basis, less than or equal to 50% of cubic boron nitride grains each having an equivalent circle diameter of more than 2 µm, and when a mass of the cubic boron nitride grains is assumed as 100 mass%, a total content of lithium, magnesium, calcium, strontium, beryllium, and barium in the cubic boron nitride grains is less than 0.001 mass%.
Patent EP-3907743-A1 (EP)
Inventor: WU ZHENHUA
IPC: G21D3/06
Filed: 2020-11-13
Abstract: The application discloses a passive pulse cooling method and system for a nuclear power plant. The method is executed when a total loss of feedwater or a total loss of feedwater due to power loss superposition of the whole plant occurs. The method comprises a steam generator isolation step, a steam generator function separation step, a cooling steam generator pressure relief step, a deaerator first-stage pressurization step, a feedwater pipeline opening step and a deaerator second-stage pressurization step. When the total loss of feedwater or the total loss of feedwater due to power loss superposition of the whole plant occurs, the function of a plurality of steam generators of the nuclear power plant are separated into two parts a power-operated steam generator and a cooling steam generator, the pressure difference between high-pressure steam in the nuclear steam supply system and the cooling steam generator is used as water injection power, high-pressure steam of the steam pipeline and the power-operated steam generator is used for pressurizing the deaerator, an atmospheric relief valve of the cooling steam generator is opened for pressure reduction, and water in the deaerator is injected into the cooling steam generator in a passive mode through the pressure difference, so water injection of the steam generator is achieved.
Patent EP-4061079-A1 (EP)
Title: Random access method and apparatus
Inventor: FEI YONGQIANG
IPC: H04W72/04
Filed: 2020-01-10
Abstract: A random access method and an apparatus. A principle of the method is as follows: A terminal device receives a first wake-up signal, and then determines N random access channel occasions based on a correspondence between the first wake-up signal and the N random access channel occasions. The terminal device determines a first random access channel occasion in the N random access channel occasions, and sends a random access preamble on the first random access channel occasion. A network device uses, as a reception beam, a beam used to send the first wake-up signal, to receive the random access preamble sent by the terminal device. A wake-up signal has advantages such as a narrow beam, a flexible beam, and a high beam gain. Therefore, when the network device receives the random access preamble by using the beam of the first wake-up signal, there are also advantages such as high flexibility and a high beam gain.
Patent EP-3982770-A1 (EP)
Inventor: LEE WON KYEONG
IPC: A24F40/50
Filed: 2020-12-22
Abstract: An aerosol generating device including: a heater configured to heat an aerosol-generating material; a battery configured to supply power to the heater; an airflow detecting sensor configured to detect a change in airflow inside the aerosol generating device; a pressure sensor configured to detect a pressure change outside the aerosol generating device; and a controller, wherein the controller may determine whether a puff has occurred based on a first sensing value received from the air flow detection sensor and a second sensing value received from the pressure sensor.
Patent EP-4015655-A1 (EP)
Inventor: DAI LIZHONG
IPC: C12Q1/6851
Filed: 2020-10-15
Abstract: Provided is a composition for detecting novel coronavirus 2019-nCoV, influenza A virus, influenza B virus, respiratory adenovirus, respiratory syncytial virus, and  Mycoplasma pneumoniae.  Also provided are a kit containing the composition, a use of the composition, and a method for detecting and typing pathogens that cause a respiratory tract infection.
Patent EP-4175955-A1 (EP)
Title: Dérivés de quinoléine, sels pharmaceutiquement acceptables et leurs procédés d'utilisation
Inventor: GADDAM BAPU
IPC: C07D471/04
Filed: 2020-07-31
Abstract: La présente invention concerne le composé acide  trans -4-[1-(3-chlorophényl)-7-méthoxy -2,4-dioxo-pyrimido [5,4-c]quinoléine-3-yl]cyclohexanecarboxylique, des sels pharmaceutiquement acceptables et leur utilisation en tant qu'agent thérapeutique notamment pout le traitement de troubles inflammatoires.
Patent EP-4218438-A1 (EP)
Title: Suction device, control device, and control method
Inventor: TEZUKA HIROSHI
IPC: A24F40/40
Filed: 2020-09-23
Abstract: The present invention improves the quality of an experience in which this suction device is used. This suction device comprises: a chamber having a first opening and a second opening; a first generation part which uses a first base material inserted through the first opening and received by the chamber to generate aerosol; a first airflow path which communicates air between a first airflow hole and the second opening; a second airflow path which communicates air between a second airflow hole and the second opening, and in which a second generation part which uses a second base material to generate aerosol is disposed midway; an opening/closing part which opens/closes each of the first airflow path and the second airflow path; and a control part which controls the operations of the first generation part and the second generation part on the basis of the opening/closing states of the first airflow path and the second airflow path.
Patent EP-4224955-A1 (EP)
Title: Communication method and apparatus
Inventor: LI RUIJIE
IPC: H04W72/00
Filed: 2020-10-22
Abstract: Embodiments of this application disclose a communication method and apparatus, to resolve a problem that a terminal device frequently sends channel state information or an uplink reference signal, so that signaling overheads of the terminal device can be reduced. The method includes: determining a first feedback information set, and sending first channel state information or a first uplink reference signal to a network device when the first feedback information set meets a first condition. The first feedback information set includes at least one piece of feedback information, and the feedback information is a negative acknowledgment NACK or an acknowledgment ACK.
Patent EP-4261960-A1 (EP)
Inventor: ISODA HIROYUKI
IPC: H01M8/04
Filed: 2020-12-10
Abstract: An in-vehicle fuel cell system, including a fuel cell, and an auxiliary machine configured to exchange a gas with the fuel cell, the in-vehicle fuel system including an auxiliary machine structure configured to accommodate the auxiliary machine, wherein the fuel cell includes a first fuel cell fixed to an upper surface of the auxiliary machine structure and a second fuel cell fixed to a lower surface of the auxiliary machine structure, the auxiliary machine structure is disposed at substantially the same position in a height direction as a skeleton member of a vehicle body, and the first fuel cell and the second fuel cell are fixed to the skeleton member via the auxiliary machine structure.
Patent EP-4024227-A1 (EP)
Inventor: POWELL TIMOTHY
IPC: G06F16/2457
Filed: 2021-01-05
Abstract: Server computers of card issuer-processors can identify an original transaction record, from among millions of stored transaction records relating to card processing transactions, based on data values of a particular input transaction and a plurality of filtering operations representing base criteria for an original transaction, first criteria strongly indicative of an original transaction, and second criteria that are weakly indicative of an original transaction. Real-time, high-speed, scalable processing is implemented for use in a high-volume transaction request-response system for payment networks or other digital data networks that are sensitive to latency.
Patent EP-3854411-A1 (EP)
Inventor: CHENG JYA-WEI
IPC: C07K14/52
Filed: 2021-01-08
Abstract: The present invention provides a novel chemokine receptor antagonistic modified peptide. The novel chemokine receptor antagonistic modified peptide can be combined with a chemotherapeutic drug for treating cancer, especially for treating drug-resistant cancer, and inhibiting tumor growth more effectively.
Patent EP-3929982-A1 (EP)
Inventor: VU LAN
IPC: H02H9/04
Filed: 2021-01-13
Abstract: Some embodiments include apparatuses having an input node; an electrostatic discharge protection circuitry including a first diode including a cathode coupled to the input node, and an anode coupled to a ground node; a second diode including an anode coupled to the input node, and a cathode coupled to a circuit node; a clamp circuit coupled to the circuit node; and a current limiting circuit coupled between the circuit node and a supply node.
Patent EP-3863020-A1 (EP)
Inventor: KURITA TOMOCHIKA
IPC: G16C60/00
Filed: 2021-01-18
Abstract: A crystalline material analysis device includes: a graph creation unit that creates a loop graph that has intra-cell nodes that indicate atoms in one unit cell of a crystalline material, an intra-cell edge that indicates a chemical bond between atoms in the unit cell, and a loop edge that indicates the chemical bond, which is virtual, between atom X in the unit cell and atom Y in the unit cell corresponding to atom Y' in an adjacent unit cell that is adjacent to the unit cell, in which the atom Y' has the chemical bond with the atom X; and an analysis unit that analyzes the crystalline material by using the graph.
Patent EP-4039263-A1 (EP)
Inventor: SAITA MARIA GRAZIA
IPC: A61K38/03
Filed: 2021-02-04
Abstract: The present patent application relates to formulations for ophthalmic application used in the treatment of asthenopia.